Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Aimmune Therap (AIMT)

Aimmune Therap (AIMT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Aimmune Therap 8000 MARINA BOULEVARD SUITE 300 BRISBANE CA 94005 USA

www.aimmune.com P: 650-614-5220

Description:

Aimmune Therapeutics, Inc. is a biopharmaceutical company which is engaged in the development of desensitization treatments for peanut and other food allergies. The Company's characterized oral desensitization immunotherapy includes AR101, a product for the treatment of peanut allergy in children and adults which is in clinical trial stage. Aimmune Therapeutics, Inc. is headquartered in Brisbane, California.

Key Statistics

Overview:

Market Capitalization, $K 2,257,370
Shares Outstanding, K 65,450
Annual Sales, $ 0 K
Annual Net Income, $ -248,500 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -69,240 K
60-Month Beta 1.76
% of Insider Shareholders 13.75%
% of Institutional Shareholders 74.47%
Float, K 56,451
% Float 86.25%

Growth:

1-Year Return 40.49%
3-Year Return 34.41%
5-Year Return 127.66%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth -4.47%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -1.06 on 07/30/20
Latest Earnings Date 11/04/20
Earnings Per Share ttm -4.33
EPS Growth vs. Prev Qtr 10.17%
EPS Growth vs. Prev Year -4.95%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

AIMT Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -164.99%
Return-on-Assets % -89.50%
Profit Margin % 0.00%
Debt/Equity 0.73
Price/Sales 3,892.02
Price/Cash Flow N/A
Price/Book 12.55
Book Value/Share 2.75
Interest Coverage -49.36
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar